Evolent Health Inc (NYSE:EVH) – Research analysts at William Blair issued their FY2019 earnings per share estimates for Evolent Health in a report issued on Wednesday. William Blair analyst R. Daniels anticipates that the technology company will post earnings per share of $0.03 for the year.
Evolent Health (NYSE:EVH) last issued its quarterly earnings results on Thursday, November 2nd. The technology company reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.04. The company had revenue of $107.90 million for the quarter, compared to the consensus estimate of $104.49 million. Evolent Health had a negative return on equity of 5.05% and a negative net margin of 15.86%. The company’s revenue for the quarter was up 79.2% on a year-over-year basis. During the same period in the previous year, the business posted ($0.26) EPS.
Several other research analysts also recently commented on EVH. KeyCorp started coverage on Evolent Health in a research report on Tuesday, September 19th. They issued an “overweight” rating and a $23.00 price target on the stock. SunTrust Banks reaffirmed a “buy” rating and issued a $30.00 price target on shares of Evolent Health in a research report on Wednesday, September 20th. Robert W. Baird reaffirmed an “outperform” rating and issued a $25.00 price target (down from $35.00) on shares of Evolent Health in a research report on Tuesday, September 26th. They noted that the move was a valuation call. Zacks Investment Research downgraded Evolent Health from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. Finally, Cowen reissued an “outperform” rating and set a $29.00 price objective (down previously from $33.00) on shares of Evolent Health in a report on Friday, October 6th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have assigned a buy rating to the stock. Evolent Health currently has a consensus rating of “Buy” and an average price target of $28.00.
Shares of Evolent Health (NYSE EVH) traded up $0.45 during midday trading on Monday, reaching $15.05. The company’s stock had a trading volume of 1,498,800 shares, compared to its average volume of 1,200,967. The company has a current ratio of 3.34, a quick ratio of 3.34 and a debt-to-equity ratio of 0.11. The company has a market cap of $1,160.00 and a P/E ratio of -13.20. Evolent Health has a 52 week low of $10.30 and a 52 week high of $27.50.
Several large investors have recently made changes to their positions in EVH. FMR LLC grew its holdings in shares of Evolent Health by 117.7% during the 2nd quarter. FMR LLC now owns 9,864,775 shares of the technology company’s stock worth $250,073,000 after purchasing an additional 5,333,252 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Evolent Health by 37.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 7,465,019 shares of the technology company’s stock valued at $136,236,000 after buying an additional 2,026,893 shares in the last quarter. Vanguard Group Inc. boosted its stake in Evolent Health by 48.9% in the 2nd quarter. Vanguard Group Inc. now owns 3,769,869 shares of the technology company’s stock valued at $95,566,000 after buying an additional 1,237,941 shares in the last quarter. Kornitzer Capital Management Inc. KS acquired a new stake in Evolent Health in the 3rd quarter valued at $14,258,000. Finally, Jennison Associates LLC acquired a new stake in Evolent Health in the 3rd quarter valued at $12,531,000. 95.38% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This story was first published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://transcriptdaily.com/2018/01/15/william-blair-comments-on-evolent-health-incs-fy2019-earnings-evh.html.
Evolent Health Company Profile
Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.